Words of the President

Where expertise meets drug development needs

“Our clients in the bio/pharmaceutical industry are facing a challenging environment when developing new drugs or new formulations for the global market: plenty of scientific, quality and regulatory questions have to be solved with high expertise and reliable know-how to allow an adequate time-to-market. The ambition of SYNEXEL Research International is to provide our expert services in bioanalysis at different stages of the drug development process – your needs become our challenges. Our commitment to satisfy and exceed your expectations has first priority. In this sense, I look forward working with you in a trusted partnership to break new ground for an exciting and mutually beneficial future.”

Dr. Sabine LEHMANN, President of SYNEXEL Research International SAS